Do benzodiazepines mimic reverse-turn structures?

@article{Hata2006DoBM,
  title={Do benzodiazepines mimic reverse-turn structures?},
  author={Masayuki Hata and Garland R. Marshall},
  journal={Journal of Computer-Aided Molecular Design},
  year={2006},
  volume={20},
  pages={321-331}
}
  • M. Hata, G. Marshall
  • Published 14 September 2006
  • Chemistry
  • Journal of Computer-Aided Molecular Design
The role of benzodiazepine derivatives (BZD) as a privileged scaffold that mimics β-turn structures (Ripka et al. (1993) Tetrahedron 49:3593–3608) in peptide/protein recognition was reexamined in detail. Stable BZD ring conformers were determined with MM3, and experimental reverse-turn structures were extracted from the basis set of protein crystal structures previously defined by Ripka et al. Ideal β-turns were also modeled and similarly compared with BZD conformers. Huge numbers of conformers… 
γ-Turn Mimicry with Benzodiazepinones and Pyrrolobenzodiazepinones Synthesized from a Common Amino Ketone Intermediate.
TLDR
Comparison of dihedral angle values for the amino acid component from X-ray analyses of 4g, 5f, and 6f and related diazepinones has catalogued the manner by which ring substituents affect the component's ability to mimic the central residues of γ-turns.
Synthesis of rhenium-centric reverse turn mimics.
TLDR
It is shown that amino acid sequences can be assembled, reduced and coordinated on-resin, resulting in a versatile set of metal-ligand constructs, which could be expanded to generate libraries of turn-based peptidomimetics containing Re/Tc(I) organometallic scaffolds.
Privileged scaffolds targeting reverse-turn and helix recognition
TLDR
Privileged scaffolds targeting common protein-recognition motifs are useful to help elucidate the receptor-bound conformation and to provide non-peptidic, bioavailable substructures suitable for optimization to modulate protein–protein interactions.
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes
TLDR
A new classification of peptidomimetics (classes A–D) is introduced that enables a clear assignment of available approaches for the structure-based design of PPI inhibitors through stabilizing or mimicking turns, β-sheets, and helices.
1,4-Diazepines
Molecular Modeling Suggests Conformational Scaffolds Specifically Targeting Five Subtypes of Somatostatin Receptors
TLDR
The results help rationalize experimental observations on the specificity of binding of various somatostatin analogs with different subtypes of the SSTRs and serve as templates for the design of conformationally constrained non‐peptide scaffolds that effectively and selectively interact with differentSubtypes of Sstrs.
Chemogenomics with protein secondary-structure mimetics.
TLDR
In this chapter, current progress in the design and synthesis of semirigid molecular scaffolds on which to display amino acid side chains is reviewed.
Use of secondary structure element information in drug design: polypharmacology and conserved motifs in protein-ligand binding and protein-protein interfaces.
  • O. Koch
  • Biology, Chemistry
    Future medicinal chemistry
  • 2011
TLDR
The concepts and ideas based on secondary structure element similarities and their successful applications in drug design are reviewed and discussed.
Reversal of diastereoselectivity in the synthesis of peptidomimetic 3-carboxamide-1,4-benzodiazepin-5-ones.
Enantiopure 3-carboxamide-1,4-benzodiazepin-5-ones were synthesized via the Ugi reaction followed by the Staudinger/aza-Wittig or reduction reactions in only two steps. A complete reversal of
An in-tether sulfilimine chiral center induces β-turn conformation in short peptides.
A sulfilimine chiral center in the tether at i, i + 3 positions of short peptides was systematically studied to elucidate the chirality-driven conformational changes. A rare and unexpected type III
...
...

References

SHOWING 1-10 OF 33 REFERENCES
Metal complexes of chiral pentaazacrowns as conformational templates for β-turn recognition
TLDR
This study evaluates the potential of metal complexes of chiral pentaazacrowns (PAC) derived by reduction of cyclic pentapeptides asβ-turn mimetics and utilizes a simple geometrical comparison between the experimental data for crystalline PAC complexes and the side-chain orientations seen in classic β-turns.
Topological side-chain classification of β-turns: Ideal motifs for peptidomimetic development
TLDR
The mean structures of the nine clusters are useful for the development of β-turn mimetics and as biological descriptors for focusing combinatorial chemistry towards biologically relevant topological space.
NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal beta-turns.
TLDR
The results presented support the hypothesis that high-affinity bradykinin receptor antagonists must adopt C-terminal beta-turn conformations.
Conformation-function relationships in LHRH analogs. II. Conformations of LHRH peptide agonists and antagonists.
TLDR
LHRH antagonists considered in this study were shown to possess low-energy structures, with the spatial arrangement of the residues in the N-terminal tripeptide similar to that of agonists.
Conformation-function relationships in LHRH analogs. I. Conformations of LHRH peptide backbone.
A systematic conformational build-up procedure was performed for the LHRH molecule, pGlu1-His2-Trp3-Ser4-Tyr5-Gly6-Leu7-Arg8-Pro9-Gly10-NH 2. The results showed a very high flexibility of the LHRH
Turns in peptides and proteins.
A revised set of potentials for β‐turn formation in proteins
Three thousand eight hundred ninety‐nine β‐turns have been identified and classified using a nonhomologous data set of 205 protein chains. These were used to derive β‐turn positional potentials for
Design of β-turn Based Therapeutic Agents
TLDR
This review highlights the importance of beta- turn in the design of various peptidomimetics for many diseases and outlines several beta-turn mimicking strategies and its application in theDesign of potent peptide analogues.
Three-dimensional recognition requirements for angiotensin agonists: a novel solution for an old problem.
A novel approach involving the search for a common spatial arrangement of functionally important (pharmacophoric) groups in low-energy conformers of AT and its active analogs has been employed to
...
...